VNDA Financial Facts
Income (loss) from operations: -653KNet income (loss): -430K
See Full Income Statement
Total assets: 208.44M
Marketable securities: 109.81M
See Full Balance Sheet
Vanda Pharma (VNDA) Earnings
|
Expand Research on VNDA
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -13.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | -$0.69 | N/A | N/A | $54.28M | = | N/A | N/A | ||
| 2/11/26 | Q425 | -$1.81 | -$0.98 | -$0.83 | $33.22M | $59.28M | = |  | | Details | |
| 10/29/25 | Q325 | -$0.38 | -$0.43 | +$0.05 | $56.26M | $58.83M | = | | | Details | |
| 7/31/25 | Q225 | -$0.46 | -$0.29 | -$0.17 | $52.59M | $55.1M | = | | | Details | |
| 5/7/25 | Q125 | $0.00 | -$0.02 | +$0.02 | $50.04M | $61.02M | = | | | Details | |
| 5/2/25 |
Q125 | N/A | -$0.02 | N/A | N/A | $61.02M | = | N/A | N/A | ||
| 4/30/25 |
Q125 | N/A | -$0.02 | N/A | N/A | $61.02M | = | N/A | N/A | ||
| 2/13/25 | Q424 | -$0.08 | -$0.17 | +$0.09 | $53.2M | $51.23M | = | | | Details |
